ICG- Liver Test Versus New Biomarkers as Prognostic Markers in Critically Ill Patients

ICG- Liver Test Versus New Biomarkers as Prognostic Markers in Critically Ill

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01126554

Acronym

Greenpep

Enrollment

110

Registered

2010-05-19

Start date

2010-07-31

Completion date

2011-02-28

Last updated

2014-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically Ill

Keywords

Prognostic value

Brief summary

Comparison of ICG liver testing with copeptin and SAPS II score as prognostic markers in critically ill patients.

Detailed description

Comparison of different marker for length of stay in the ICU in critically ill patients.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* All patients admitted to the ICU

Exclusion criteria

* Not able to understand German

Design outcomes

Primary

Measure	Time frame	Description
prolonged length of stay in the ICU (pLOS) more than 3 days	3 days	see above

Countries

Switzerland

Outcome results